Join the U.S. Progress Point Subscribers' Circle
First looks, exclusive content, and more.
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Life Sciences
-
Healthcare
Life Sciences
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences
Healthcare
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREBLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
PODCASTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTSGerman White Paper
How Will We Remember This Moment? An Alzheimer's Perspective
The second disease-modifying Alzheimer's treatment is here with more on the horizon, but is the healthcare ecosystem ready for their impact?
Nov 03, 2023
For the first time, patients living with Alzheimer's disease (AD) and their families have options. Yet, the recent approvals and market performance of disease-modifying treatments demonstrate a glaring truth: The healthcare system is unprepared to deliver the hope that these new treatments promise.
In this paper, we tackle what is needed to reach as many patients as possible, diving deep into the alignment that must exist in and between five key areas: advocacy, approval, adoption, access, and adherence. With an intentional focus on each, and the connectivity between them, the all-stakeholder empowerment needed to best serve patients and their families can (and will) be achieved.
New feature: Scroll down to access the audio version of this insight brief!
Audio Reading - How Will We Remember This Moment? An Alzheimer’s Perspective